APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Epidemiology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artificial Intelligence in Epidemiology Market Analysis and Forecast 2026-2032

4 January 2026216 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Epidemiology Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Epidemiology Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Epidemiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Epidemiology Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Epidemiology Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Epidemiology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence in Epidemiology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence in Epidemiology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Intelligence in Epidemiology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence in Epidemiology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence in Epidemiology include Abbott Informatics, AdvancedMD, Agilent Technologies, Allscripts Healthcare, Athenahealth, Autoscribe Informatics, Cerner Corporation, Change Healthcare and Cognizant, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence in Epidemiology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence in Epidemiology, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence in Epidemiology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Epidemiology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence in Epidemiology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence in Epidemiology revenue, projected growth trends, production technology, application and end-user industry.

Artificial Intelligence in Epidemiology Segment by Company

Abbott Informatics

AdvancedMD

Agilent Technologies

Allscripts Healthcare

Athenahealth

Autoscribe Informatics

Cerner Corporation

Change Healthcare

Cognizant

CPSI

CureMD Healthcare

eClinicalWorks

e-Mds Inc.

Epic Systems

GE Healthcare

Google

Graphcore

Greenway Health

IBM

Intel

InterSystems

Kareo

Medhost

Meditech

Medtronic

Micron Technology

Microsoft

NextGen Healthcare

Nvidia

Optum Inc.

Artificial Intelligence in Epidemiology Segment by Type

Hardware Technology

Software Technology

Artificial Intelligence in Epidemiology Segment by Application

Disease and Syndromic Surveillance

Infection Prediction and Forecasting

Immunization Information Systems

Public Sentiment Analysis

Environmental Impact Analysis

Drug Discovery, Safety, and Risk Analysis

Monitoring Population and Incidence

Knowledge Representation and Mass Notification

Artificial Intelligence in Epidemiology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Epidemiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Epidemiology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Epidemiology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artificial Intelligence in Epidemiology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artificial Intelligence in Epidemiology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Epidemiology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Epidemiology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hardware Technology Major Player Table 3. Software Technology Major Player Table 4. Global Artificial Intelligence in Epidemiology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Disease and Syndromic Surveillance Major Player Table 6. Infection Prediction and Forecasting Major Player Table 7. Immunization Information Systems Major Player Table 8. Public Sentiment Analysis Major Player Table 9. Environmental Impact Analysis Major Player Table 10. Drug Discovery, Safety, and Risk Analysis Major Player Table 11. Monitoring Population and Incidence Major Player Table 12. Knowledge Representation and Mass Notification Major Player Table 13. Artificial Intelligence in Epidemiology Industry Trends Table 14. Artificial Intelligence in Epidemiology Industry Drivers Table 15. Artificial Intelligence in Epidemiology Industry Opportunities and Challenges Table 16. Artificial Intelligence in Epidemiology Industry Restraints Table 17. Global Artificial Intelligence in Epidemiology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Artificial Intelligence in Epidemiology Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Artificial Intelligence in Epidemiology Market Share by Region (2021-2026) Table 20. Global Artificial Intelligence in Epidemiology Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Artificial Intelligence in Epidemiology Market Share by Region (2027-2032) Table 22. Global Artificial Intelligence in Epidemiology Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Artificial Intelligence in Epidemiology Revenue Market Share by Players (2021-2026) Table 24. Global Artificial Intelligence in Epidemiology Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Artificial Intelligence in Epidemiology Key Players Headquarters & Area Served Table 26. Global Artificial Intelligence in Epidemiology Players, Product Type & Application Table 27. Global Artificial Intelligence in Epidemiology Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Artificial Intelligence in Epidemiology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Artificial Intelligence in Epidemiology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Artificial Intelligence in Epidemiology Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Artificial Intelligence in Epidemiology Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Artificial Intelligence in Epidemiology Revenue Market Share by Type (2021-2026) Table 34. Global Artificial Intelligence in Epidemiology Revenue Market Share by Type (2027-2032) Table 35. Global Artificial Intelligence in Epidemiology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Artificial Intelligence in Epidemiology Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Artificial Intelligence in Epidemiology Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2021-2026) Table 39. Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2027-2032) Table 40. Abbott Informatics Company Information Table 41. Abbott Informatics Business Overview Table 42. Abbott Informatics Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 44. Abbott Informatics Recent Development Table 45. AdvancedMD Company Information Table 46. AdvancedMD Business Overview Table 47. AdvancedMD Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio Table 49. AdvancedMD Recent Development Table 50. Agilent Technologies Company Information Table 51. Agilent Technologies Business Overview Table 52. Agilent Technologies Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio Table 54. Agilent Technologies Recent Development Table 55. Allscripts Healthcare Company Information Table 56. Allscripts Healthcare Business Overview Table 57. Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 59. Allscripts Healthcare Recent Development Table 60. Athenahealth Company Information Table 61. Athenahealth Business Overview Table 62. Athenahealth Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Athenahealth Artificial Intelligence in Epidemiology Product Portfolio Table 64. Athenahealth Recent Development Table 65. Autoscribe Informatics Company Information Table 66. Autoscribe Informatics Business Overview Table 67. Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio Table 69. Autoscribe Informatics Recent Development Table 70. Cerner Corporation Company Information Table 71. Cerner Corporation Business Overview Table 72. Cerner Corporation Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio Table 74. Cerner Corporation Recent Development Table 75. Change Healthcare Company Information Table 76. Change Healthcare Business Overview Table 77. Change Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 79. Change Healthcare Recent Development Table 80. Cognizant Company Information Table 81. Cognizant Business Overview Table 82. Cognizant Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Cognizant Artificial Intelligence in Epidemiology Product Portfolio Table 84. Cognizant Recent Development Table 85. CPSI Company Information Table 86. CPSI Business Overview Table 87. CPSI Artificial Intelligence in Epidemiology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. CPSI Artificial Intelligence in Epidemiology Product Portfolio Table 89. CPSI Recent Development Table 90. CureMD Healthcare Company Information Table 91. CureMD Healthcare Business Overview Table 92. CureMD Healthcare Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 94. CureMD Healthcare Recent Development Table 95. eClinicalWorks Company Information Table 96. eClinicalWorks Business Overview Table 97. eClinicalWorks Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio Table 99. eClinicalWorks Recent Development Table 100. e-Mds Inc. Company Information Table 101. e-Mds Inc. Business Overview Table 102. e-Mds Inc. Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 104. e-Mds Inc. Recent Development Table 105. Epic Systems Company Information Table 106. Epic Systems Business Overview Table 107. Epic Systems Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Epic Systems Artificial Intelligence in Epidemiology Product Portfolio Table 109. Epic Systems Recent Development Table 110. GE Healthcare Company Information Table 111. GE Healthcare Business Overview Table 112. GE Healthcare Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 114. GE Healthcare Recent Development Table 115. Google Company Information Table 116. Google Business Overview Table 117. Google Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Google Artificial Intelligence in Epidemiology Product Portfolio Table 119. Google Recent Development Table 120. Graphcore Company Information Table 121. Graphcore Business Overview Table 122. Graphcore Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Graphcore Artificial Intelligence in Epidemiology Product Portfolio Table 124. Graphcore Recent Development Table 125. Greenway Health Company Information Table 126. Greenway Health Business Overview Table 127. Greenway Health Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Greenway Health Artificial Intelligence in Epidemiology Product Portfolio Table 129. Greenway Health Recent Development Table 130. IBM Company Information Table 131. IBM Business Overview Table 132. IBM Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. IBM Artificial Intelligence in Epidemiology Product Portfolio Table 134. IBM Recent Development Table 135. Intel Company Information Table 136. Intel Business Overview Table 137. Intel Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Intel Artificial Intelligence in Epidemiology Product Portfolio Table 139. Intel Recent Development Table 140. InterSystems Company Information Table 141. InterSystems Business Overview Table 142. InterSystems Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. InterSystems Artificial Intelligence in Epidemiology Product Portfolio Table 144. InterSystems Recent Development Table 145. Kareo Company Information Table 146. Kareo Business Overview Table 147. Kareo Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. Kareo Artificial Intelligence in Epidemiology Product Portfolio Table 149. Kareo Recent Development Table 150. Medhost Company Information Table 151. Medhost Business Overview Table 152. Medhost Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 153. Medhost Artificial Intelligence in Epidemiology Product Portfolio Table 154. Medhost Recent Development Table 155. Meditech Company Information Table 156. Meditech Business Overview Table 157. Meditech Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 158. Meditech Artificial Intelligence in Epidemiology Product Portfolio Table 159. Meditech Recent Development Table 160. Medtronic Company Information Table 161. Medtronic Business Overview Table 162. Medtronic Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 163. Medtronic Artificial Intelligence in Epidemiology Product Portfolio Table 164. Medtronic Recent Development Table 165. Micron Technology Company Information Table 166. Micron Technology Business Overview Table 167. Micron Technology Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 168. Micron Technology Artificial Intelligence in Epidemiology Product Portfolio Table 169. Micron Technology Recent Development Table 170. Microsoft Company Information Table 171. Microsoft Business Overview Table 172. Microsoft Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 173. Microsoft Artificial Intelligence in Epidemiology Product Portfolio Table 174. Microsoft Recent Development Table 175. NextGen Healthcare Company Information Table 176. NextGen Healthcare Business Overview Table 177. NextGen Healthcare Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 178. NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio Table 179. NextGen Healthcare Recent Development Table 180. Nvidia Company Information Table 181. Nvidia Business Overview Table 182. Nvidia Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 183. Nvidia Artificial Intelligence in Epidemiology Product Portfolio Table 184. Nvidia Recent Development Table 185. Optum Inc. Company Information Table 186. Optum Inc. Business Overview Table 187. Optum Inc. Artificial Intelligence in Epidemiology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 188. Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio Table 189. Optum Inc. Recent Development Table 190. North America Artificial Intelligence in Epidemiology Revenue by Type (2021-2026) & (US$ Million) Table 191. North America Artificial Intelligence in Epidemiology Revenue by Type (2027-2032) & (US$ Million) Table 192. North America Artificial Intelligence in Epidemiology Revenue by Application (2021-2026) & (US$ Million) Table 193. North America Artificial Intelligence in Epidemiology Revenue by Application (2027-2032) & (US$ Million) Table 194. North America Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. North America Artificial Intelligence in Epidemiology Revenue by Country (2021-2026) & (US$ Million) Table 196. North America Artificial Intelligence in Epidemiology Revenue by Country (US$ Million) & (2027-2032) Table 197. Europe Artificial Intelligence in Epidemiology Revenue by Type (2021-2026) & (US$ Million) Table 198. Europe Artificial Intelligence in Epidemiology Revenue by Type (2027-2032) & (US$ Million) Table 199. Europe Artificial Intelligence in Epidemiology Revenue by Application (2021-2026) & (US$ Million) Table 200. Europe Artificial Intelligence in Epidemiology Revenue by Application (2027-2032) & (US$ Million) Table 201. Europe Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. Europe Artificial Intelligence in Epidemiology Revenue by Country (2021-2026) & (US$ Million) Table 203. Europe Artificial Intelligence in Epidemiology Revenue by Country (US$ Million) & (2027-2032) Table 204. China Artificial Intelligence in Epidemiology Revenue by Type (2021-2026) & (US$ Million) Table 205. China Artificial Intelligence in Epidemiology Revenue by Type (2027-2032) & (US$ Million) Table 206. China Artificial Intelligence in Epidemiology Revenue by Application (2021-2026) & (US$ Million) Table 207. China Artificial Intelligence in Epidemiology Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Artificial Intelligence in Epidemiology Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Artificial Intelligence in Epidemiology Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Artificial Intelligence in Epidemiology Revenue by Application (2021-2026) & (US$ Million) Table 211. Asia Artificial Intelligence in Epidemiology Revenue by Application (2027-2032) & (US$ Million) Table 212. Asia Artificial Intelligence in Epidemiology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Artificial Intelligence in Epidemiology Revenue by Region (US$ Million) & (2021-2026) Table 214. Asia Artificial Intelligence in Epidemiology Revenue by Region (US$ Million) & (2027-2032) Table 215. SAMEA Artificial Intelligence in Epidemiology Revenue by Type (2021-2026) & (US$ Million) Table 216. SAMEA Artificial Intelligence in Epidemiology Revenue by Type (2027-2032) & (US$ Million) Table 217. SAMEA Artificial Intelligence in Epidemiology Revenue by Application (2021-2026) & (US$ Million) Table 218. SAMEA Artificial Intelligence in Epidemiology Revenue by Application (2027-2032) & (US$ Million) Table 219. SAMEA Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. SAMEA Artificial Intelligence in Epidemiology Revenue by Country (2021-2026) & (US$ Million) Table 221. SAMEA Artificial Intelligence in Epidemiology Revenue by Country (US$ Million) & (2027-2032) Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Artificial Intelligence in Epidemiology Image Figure 2. Global Artificial Intelligence in Epidemiology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Epidemiology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hardware Technology Image Figure 5. Software Technology Image Figure 6. Global Artificial Intelligence in Epidemiology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Artificial Intelligence in Epidemiology Market Size Share 2021 VS 2025 VS 2032 Figure 8. Disease and Syndromic Surveillance Image Figure 9. Infection Prediction and Forecasting Image Figure 10. Immunization Information Systems Image Figure 11. Public Sentiment Analysis Image Figure 12. Environmental Impact Analysis Image Figure 13. Drug Discovery, Safety, and Risk Analysis Image Figure 14. Monitoring Population and Incidence Image Figure 15. Knowledge Representation and Mass Notification Image Figure 16. Global Artificial Intelligence in Epidemiology Market Size (US$ Million) & (2021-2032) Figure 17. Global Artificial Intelligence in Epidemiology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Artificial Intelligence in Epidemiology Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Artificial Intelligence in Epidemiology Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Artificial Intelligence in Epidemiology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Artificial Intelligence in Epidemiology Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Artificial Intelligence in Epidemiology Revenue Market Share by Type (2021-2032) Figure 24. Global Artificial Intelligence in Epidemiology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2021-2032) Figure 27. North America Artificial Intelligence in Epidemiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032) Figure 29. North America Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032) Figure 30. North America Artificial Intelligence in Epidemiology Revenue Share by Country (2021-2032) Figure 31. United States Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Artificial Intelligence in Epidemiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032) Figure 36. Europe Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032) Figure 37. Europe Artificial Intelligence in Epidemiology Revenue Share by Country (2021-2032) Figure 38. Germany Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Artificial Intelligence in Epidemiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032) Figure 48. China Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032) Figure 49. Asia Artificial Intelligence in Epidemiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032) Figure 51. Asia Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032) Figure 52. Asia Artificial Intelligence in Epidemiology Revenue Share by Region (2021-2032) Figure 53. Japan Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Artificial Intelligence in Epidemiology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032) Figure 61. SAMEA Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032) Figure 62. SAMEA Artificial Intelligence in Epidemiology Revenue Share by Country (2021-2032) Figure 63. Brazil Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Artificial Intelligence in Epidemiology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware Technology
  • Software Technology
Applications
  • Disease and Syndromic Surveillance
  • Infection Prediction and Forecasting
  • Immunization Information Systems
  • Public Sentiment Analysis
  • Environmental Impact Analysis
  • Drug Discovery, Safety, and Risk Analysis
  • Monitoring Population and Incidence
  • Knowledge Representation and Mass Notification
Companies covered
  • Abbott Informatics
  • AdvancedMD
  • Agilent Technologies
  • Allscripts Healthcare
  • Athenahealth
  • Autoscribe Informatics
  • Cerner Corporation
  • Change Healthcare
  • Cognizant
  • CPSI
  • CureMD Healthcare
  • eClinicalWorks
  • e-Mds Inc.
  • Epic Systems
  • GE Healthcare
  • Google
  • Graphcore
  • Greenway Health
  • IBM
  • Intel
  • InterSystems
  • Kareo
  • Medhost
  • Meditech
  • Medtronic
  • Micron Technology
  • Microsoft
  • NextGen Healthcare
  • Nvidia
  • Optum Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Intelligence in Epidemiology Market by Type
  3. 1.2.1 Global Artificial Intelligence in Epidemiology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hardware Technology
  5. 1.2.3 Software Technology
  6. 1.3 Artificial Intelligence in Epidemiology Market by Application
  7. 1.3.1 Global Artificial Intelligence in Epidemiology Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Disease and Syndromic Surveillance
  9. 1.3.3 Infection Prediction and Forecasting
  10. 1.3.4 Immunization Information Systems
  11. 1.3.5 Public Sentiment Analysis
  12. 1.3.6 Environmental Impact Analysis
  13. 1.3.7 Drug Discovery, Safety, and Risk Analysis
  14. 1.3.8 Monitoring Population and Incidence
  15. 1.3.9 Knowledge Representation and Mass Notification
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Epidemiology Market Dynamics
  1. 2.1 Artificial Intelligence in Epidemiology Industry Trends
  2. 2.2 Artificial Intelligence in Epidemiology Industry Drivers
  3. 2.3 Artificial Intelligence in Epidemiology Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Epidemiology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artificial Intelligence in Epidemiology Market Perspective (2021-2032)
  2. 3.2 Global Artificial Intelligence in Epidemiology Growth Trends by Region
  3. 3.2.1 Global Artificial Intelligence in Epidemiology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Intelligence in Epidemiology Market Size by Region (2021-2026)
  5. 3.2.3 Global Artificial Intelligence in Epidemiology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artificial Intelligence in Epidemiology Revenue by Players
  2. 4.1.1 Global Artificial Intelligence in Epidemiology Revenue by Players (2021-2026)
  3. 4.1.2 Global Artificial Intelligence in Epidemiology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artificial Intelligence in Epidemiology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Intelligence in Epidemiology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artificial Intelligence in Epidemiology Key Players Headquarters & Area Served
  7. 4.4 Global Artificial Intelligence in Epidemiology Players, Product Type & Application
  8. 4.5 Global Artificial Intelligence in Epidemiology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artificial Intelligence in Epidemiology Market CR5 and HHI
  11. 4.6.3 2025 Artificial Intelligence in Epidemiology Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence in Epidemiology Market Size by Type
  1. 5.1 Global Artificial Intelligence in Epidemiology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence in Epidemiology Revenue by Type (2021-2032)
  3. 5.3 Global Artificial Intelligence in Epidemiology Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence in Epidemiology Market Size by Application
  1. 6.1 Global Artificial Intelligence in Epidemiology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artificial Intelligence in Epidemiology Revenue by Application (2021-2032)
  3. 6.3 Global Artificial Intelligence in Epidemiology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott Informatics
  2. 7.1.1 Abbott Informatics Company Information
  3. 7.1.2 Abbott Informatics Business Overview
  4. 7.1.3 Abbott Informatics Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Informatics Artificial Intelligence in Epidemiology Product Portfolio
  6. 7.1.5 Abbott Informatics Recent Developments
  7. 7.2 AdvancedMD
  8. 7.2.1 AdvancedMD Company Information
  9. 7.2.2 AdvancedMD Business Overview
  10. 7.2.3 AdvancedMD Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AdvancedMD Artificial Intelligence in Epidemiology Product Portfolio
  12. 7.2.5 AdvancedMD Recent Developments
  13. 7.3 Agilent Technologies
  14. 7.3.1 Agilent Technologies Company Information
  15. 7.3.2 Agilent Technologies Business Overview
  16. 7.3.3 Agilent Technologies Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies Artificial Intelligence in Epidemiology Product Portfolio
  18. 7.3.5 Agilent Technologies Recent Developments
  19. 7.4 Allscripts Healthcare
  20. 7.4.1 Allscripts Healthcare Company Information
  21. 7.4.2 Allscripts Healthcare Business Overview
  22. 7.4.3 Allscripts Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Allscripts Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  24. 7.4.5 Allscripts Healthcare Recent Developments
  25. 7.5 Athenahealth
  26. 7.5.1 Athenahealth Company Information
  27. 7.5.2 Athenahealth Business Overview
  28. 7.5.3 Athenahealth Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Athenahealth Artificial Intelligence in Epidemiology Product Portfolio
  30. 7.5.5 Athenahealth Recent Developments
  31. 7.6 Autoscribe Informatics
  32. 7.6.1 Autoscribe Informatics Company Information
  33. 7.6.2 Autoscribe Informatics Business Overview
  34. 7.6.3 Autoscribe Informatics Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Autoscribe Informatics Artificial Intelligence in Epidemiology Product Portfolio
  36. 7.6.5 Autoscribe Informatics Recent Developments
  37. 7.7 Cerner Corporation
  38. 7.7.1 Cerner Corporation Company Information
  39. 7.7.2 Cerner Corporation Business Overview
  40. 7.7.3 Cerner Corporation Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Cerner Corporation Artificial Intelligence in Epidemiology Product Portfolio
  42. 7.7.5 Cerner Corporation Recent Developments
  43. 7.8 Change Healthcare
  44. 7.8.1 Change Healthcare Company Information
  45. 7.8.2 Change Healthcare Business Overview
  46. 7.8.3 Change Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Change Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  48. 7.8.5 Change Healthcare Recent Developments
  49. 7.9 Cognizant
  50. 7.9.1 Cognizant Company Information
  51. 7.9.2 Cognizant Business Overview
  52. 7.9.3 Cognizant Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Cognizant Artificial Intelligence in Epidemiology Product Portfolio
  54. 7.9.5 Cognizant Recent Developments
  55. 7.10 CPSI
  56. 7.10.1 CPSI Company Information
  57. 7.10.2 CPSI Business Overview
  58. 7.10.3 CPSI Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CPSI Artificial Intelligence in Epidemiology Product Portfolio
  60. 7.10.5 CPSI Recent Developments
  61. 7.11 CureMD Healthcare
  62. 7.11.1 CureMD Healthcare Company Information
  63. 7.11.2 CureMD Healthcare Business Overview
  64. 7.11.3 CureMD Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CureMD Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  66. 7.11.5 CureMD Healthcare Recent Developments
  67. 7.12 eClinicalWorks
  68. 7.12.1 eClinicalWorks Company Information
  69. 7.12.2 eClinicalWorks Business Overview
  70. 7.12.3 eClinicalWorks Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 eClinicalWorks Artificial Intelligence in Epidemiology Product Portfolio
  72. 7.12.5 eClinicalWorks Recent Developments
  73. 7.13 e-Mds Inc.
  74. 7.13.1 e-Mds Inc. Company Information
  75. 7.13.2 e-Mds Inc. Business Overview
  76. 7.13.3 e-Mds Inc. Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  77. 7.13.4 e-Mds Inc. Artificial Intelligence in Epidemiology Product Portfolio
  78. 7.13.5 e-Mds Inc. Recent Developments
  79. 7.14 Epic Systems
  80. 7.14.1 Epic Systems Company Information
  81. 7.14.2 Epic Systems Business Overview
  82. 7.14.3 Epic Systems Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Epic Systems Artificial Intelligence in Epidemiology Product Portfolio
  84. 7.14.5 Epic Systems Recent Developments
  85. 7.15 GE Healthcare
  86. 7.15.1 GE Healthcare Company Information
  87. 7.15.2 GE Healthcare Business Overview
  88. 7.15.3 GE Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  89. 7.15.4 GE Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  90. 7.15.5 GE Healthcare Recent Developments
  91. 7.16 Google
  92. 7.16.1 Google Company Information
  93. 7.16.2 Google Business Overview
  94. 7.16.3 Google Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Google Artificial Intelligence in Epidemiology Product Portfolio
  96. 7.16.5 Google Recent Developments
  97. 7.17 Graphcore
  98. 7.17.1 Graphcore Company Information
  99. 7.17.2 Graphcore Business Overview
  100. 7.17.3 Graphcore Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Graphcore Artificial Intelligence in Epidemiology Product Portfolio
  102. 7.17.5 Graphcore Recent Developments
  103. 7.18 Greenway Health
  104. 7.18.1 Greenway Health Company Information
  105. 7.18.2 Greenway Health Business Overview
  106. 7.18.3 Greenway Health Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Greenway Health Artificial Intelligence in Epidemiology Product Portfolio
  108. 7.18.5 Greenway Health Recent Developments
  109. 7.19 IBM
  110. 7.19.1 IBM Company Information
  111. 7.19.2 IBM Business Overview
  112. 7.19.3 IBM Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  113. 7.19.4 IBM Artificial Intelligence in Epidemiology Product Portfolio
  114. 7.19.5 IBM Recent Developments
  115. 7.20 Intel
  116. 7.20.1 Intel Company Information
  117. 7.20.2 Intel Business Overview
  118. 7.20.3 Intel Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Intel Artificial Intelligence in Epidemiology Product Portfolio
  120. 7.20.5 Intel Recent Developments
  121. 7.21 InterSystems
  122. 7.21.1 InterSystems Company Information
  123. 7.21.2 InterSystems Business Overview
  124. 7.21.3 InterSystems Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  125. 7.21.4 InterSystems Artificial Intelligence in Epidemiology Product Portfolio
  126. 7.21.5 InterSystems Recent Developments
  127. 7.22 Kareo
  128. 7.22.1 Kareo Company Information
  129. 7.22.2 Kareo Business Overview
  130. 7.22.3 Kareo Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Kareo Artificial Intelligence in Epidemiology Product Portfolio
  132. 7.22.5 Kareo Recent Developments
  133. 7.23 Medhost
  134. 7.23.1 Medhost Company Information
  135. 7.23.2 Medhost Business Overview
  136. 7.23.3 Medhost Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Medhost Artificial Intelligence in Epidemiology Product Portfolio
  138. 7.23.5 Medhost Recent Developments
  139. 7.24 Meditech
  140. 7.24.1 Meditech Company Information
  141. 7.24.2 Meditech Business Overview
  142. 7.24.3 Meditech Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Meditech Artificial Intelligence in Epidemiology Product Portfolio
  144. 7.24.5 Meditech Recent Developments
  145. 7.25 Medtronic
  146. 7.25.1 Medtronic Company Information
  147. 7.25.2 Medtronic Business Overview
  148. 7.25.3 Medtronic Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Medtronic Artificial Intelligence in Epidemiology Product Portfolio
  150. 7.25.5 Medtronic Recent Developments
  151. 7.26 Micron Technology
  152. 7.26.1 Micron Technology Company Information
  153. 7.26.2 Micron Technology Business Overview
  154. 7.26.3 Micron Technology Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Micron Technology Artificial Intelligence in Epidemiology Product Portfolio
  156. 7.26.5 Micron Technology Recent Developments
  157. 7.27 Microsoft
  158. 7.27.1 Microsoft Company Information
  159. 7.27.2 Microsoft Business Overview
  160. 7.27.3 Microsoft Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Microsoft Artificial Intelligence in Epidemiology Product Portfolio
  162. 7.27.5 Microsoft Recent Developments
  163. 7.28 NextGen Healthcare
  164. 7.28.1 NextGen Healthcare Company Information
  165. 7.28.2 NextGen Healthcare Business Overview
  166. 7.28.3 NextGen Healthcare Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  167. 7.28.4 NextGen Healthcare Artificial Intelligence in Epidemiology Product Portfolio
  168. 7.28.5 NextGen Healthcare Recent Developments
  169. 7.29 Nvidia
  170. 7.29.1 Nvidia Company Information
  171. 7.29.2 Nvidia Business Overview
  172. 7.29.3 Nvidia Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  173. 7.29.4 Nvidia Artificial Intelligence in Epidemiology Product Portfolio
  174. 7.29.5 Nvidia Recent Developments
  175. 7.30 Optum Inc.
  176. 7.30.1 Optum Inc. Company Information
  177. 7.30.2 Optum Inc. Business Overview
  178. 7.30.3 Optum Inc. Artificial Intelligence in Epidemiology Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Optum Inc. Artificial Intelligence in Epidemiology Product Portfolio
  180. 7.30.5 Optum Inc. Recent Developments
8 North America
  1. 8.1 North America Artificial Intelligence in Epidemiology Revenue (2021-2032)
  2. 8.2 North America Artificial Intelligence in Epidemiology Revenue by Type (2021-2032)
  3. 8.2.1 North America Artificial Intelligence in Epidemiology Revenue by Type (2021-2026)
  4. 8.2.2 North America Artificial Intelligence in Epidemiology Revenue by Type (2027-2032)
  5. 8.3 North America Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032)
  6. 8.4 North America Artificial Intelligence in Epidemiology Revenue by Application (2021-2032)
  7. 8.4.1 North America Artificial Intelligence in Epidemiology Revenue by Application (2021-2026)
  8. 8.4.2 North America Artificial Intelligence in Epidemiology Revenue by Application (2027-2032)
  9. 8.5 North America Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032)
  10. 8.6 North America Artificial Intelligence in Epidemiology Revenue by Country
  11. 8.6.1 North America Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artificial Intelligence in Epidemiology Revenue by Country (2021-2026)
  13. 8.6.3 North America Artificial Intelligence in Epidemiology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Artificial Intelligence in Epidemiology Revenue (2021-2032)
  2. 9.2 Europe Artificial Intelligence in Epidemiology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artificial Intelligence in Epidemiology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artificial Intelligence in Epidemiology Revenue by Type (2027-2032)
  5. 9.3 Europe Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artificial Intelligence in Epidemiology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artificial Intelligence in Epidemiology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artificial Intelligence in Epidemiology Revenue by Application (2027-2032)
  9. 9.5 Europe Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artificial Intelligence in Epidemiology Revenue by Country
  11. 9.6.1 Europe Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artificial Intelligence in Epidemiology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artificial Intelligence in Epidemiology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Artificial Intelligence in Epidemiology Revenue (2021-2032)
  2. 10.2 China Artificial Intelligence in Epidemiology Revenue by Type (2021-2032)
  3. 10.2.1 China Artificial Intelligence in Epidemiology Revenue by Type (2021-2026)
  4. 10.2.2 China Artificial Intelligence in Epidemiology Revenue by Type (2027-2032)
  5. 10.3 China Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032)
  6. 10.4 China Artificial Intelligence in Epidemiology Revenue by Application (2021-2032)
  7. 10.4.1 China Artificial Intelligence in Epidemiology Revenue by Application (2021-2026)
  8. 10.4.2 China Artificial Intelligence in Epidemiology Revenue by Application (2027-2032)
  9. 10.5 China Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Intelligence in Epidemiology Revenue (2021-2032)
  2. 11.2 Asia Artificial Intelligence in Epidemiology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artificial Intelligence in Epidemiology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artificial Intelligence in Epidemiology Revenue by Type (2027-2032)
  5. 11.3 Asia Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artificial Intelligence in Epidemiology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artificial Intelligence in Epidemiology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artificial Intelligence in Epidemiology Revenue by Application (2027-2032)
  9. 11.5 Asia Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artificial Intelligence in Epidemiology Revenue by Country
  11. 11.6.1 Asia Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artificial Intelligence in Epidemiology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artificial Intelligence in Epidemiology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Intelligence in Epidemiology Revenue (2021-2032)
  2. 12.2 SAMEA Artificial Intelligence in Epidemiology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artificial Intelligence in Epidemiology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artificial Intelligence in Epidemiology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artificial Intelligence in Epidemiology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artificial Intelligence in Epidemiology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artificial Intelligence in Epidemiology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artificial Intelligence in Epidemiology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artificial Intelligence in Epidemiology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artificial Intelligence in Epidemiology Revenue by Country
  11. 12.6.1 SAMEA Artificial Intelligence in Epidemiology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artificial Intelligence in Epidemiology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artificial Intelligence in Epidemiology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst